Adenomyosis is rarely carcinogenic and rarely malignant. The incidence of adenomyosis has been on the rise in recent years and is positively correlated with socioeconomic status, with the increase in the rate of cesarean section, with the increase in abortions and hysteroscopic operations, and with a prevalence of about 20%-90% in patients with chronic pelvic pain and dysmenorrhea. Adenomyosis is a benign lesion, mainly due to the invasion of the endometrial glands and mesenchyme into the myometrium. It occurs mostly in menstruating mothers aged 30-50 years, about 5% of them have endometriosis and about half of them have fibroids. The main method of treatment for adenomyosis is surgery, but for women with fertility requirements, removal of the uterus is not the best option, only the uterus can be preserved, the disease is particularly prone to recurrence, as long as women have normal menstrual flow, as long as women have normal ovarian function, estrogen and progesterone function, ectopic to the uterine muscle inside the endometrium will be normal monthly exfoliation bleeding, it will lead to further development of the adenomyosis condition. After menopause, adenomyosis will gradually be controlled or disappear.